SCHEMBL8993429

SCHEMBL8993429

CS(=O)(=O)c1ncc(CF)c(C2=CCCC2)c1CF

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8993537 0.87
SCHEMBL8993563 0.82 PTGS2 (0.35) PTGS2
SCHEMBL8993497 0.69 CSF1R (0.31)
SCHEMBL8993525 0.69 LRRK2 (0.32) PTGS2
SCHEMBL8993599 0.64 PTGS2 (0.49) PTGS2
SCHEMBL8993451 0.60 PTGS2 (0.39) PTGS2
SCHEMBL15053475 0.59 HSD17B10 (0.31)
SCHEMBL16864072 0.59 PTGS2 (0.33) PTGS2
SCHEMBL8993449 0.58 PTGS2 (0.45) PTGS2
SCHEMBL8993439 0.57 PIM1 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0724566-A1 1,2-DIARYLCYCLOPENTENYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-08-07 EP disclosed
WO-1995011883-A1 1,2-DIARYLCYCLOPENTENYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1995-05-04 WO disclosed